Estoppel Applies to “Known or Used” Prior Art if PTAB Considered Corresponding Written References

Jan 4, 2019

Reading Time : 2 min

In response to the PTAB decisions, the Plaintiff in the district court moved for partial summary judgment of no invalidity of the same four claims due to IPR estoppel pursuant to 

35 U.S.C. § 315(e)(2). As the district court explained, the grounds that a petitioner reasonably could have raised in an IPR (which trigger estoppel) include prior art that a skilled researcher conducting a diligent search reasonably could have been expected to discover.

With respect to the four obviousness challenges that Plaintiff addressed in its motion for summary judgment, Defendants did not dispute that they were aware of the relevant art at the time that they filed the IPR petitions. Instead, Defendants argued that they could not have raised their district court invalidity challenges in the PTAB because they relied on the art in the district court not as “patents or printed publications” under pre-AIA
Section 102(b), but as information that was “known or used by others” before the patented inventions under pre-AIA Section 102(a)—an argument that they could not have raised at the PTAB because the PTAB’s consideration of prior art is limited to patents and printed publications. In response, Plaintiff argued, inter alia, that, where alleged prior art is a written document, the standard for establishing the reference as a “printed publication” is substantively the same as the “known or used” standard, and the relevant material must still be “publicly accessible.” Thus, according to Plaintiff, Defendants were making the same argument that they lost before the PTAB and should be estopped.

For three of the alleged invalidity challenges, the court agreed. The court found that Defendants sought to use the relevant references themselves as the basis for their invalidity arguments (as opposed to corroborative evidence). One invalidity challenge, however, included additional evidence—emails between two authors of relevant references relating to the ideas expressed in their work, and related testimony. The court noted that it was not clear whether the emails and testimony were intended to establish a reason to combine two references, as opposed to showing that certain elements of the invention were “known or used by others.” Nevertheless, and despite the court’s skepticism about the “public accessibility” issues surrounding the information in the emails and testimony, the court noted that the issue had not been squarely addressed by Plaintiff and declined to extend IPR estoppel to that challenge at the summary judgment stage. Accordingly, the district court granted Plaintiff’s motion for summary judgment of no invalidity based on IPR estoppel, except as to Defendants’ invalidity challenge that relied on the combination of prior art, testimony and email evidence.

Practice Tip: If one asserts substantively the same reference in the PTAB and a district court on a theory that the written reference is separate evidence of what was known or used by others before the invention, IPR estoppel may attach based on a final written decision by the PTAB. IPR estoppel may not attach, however, if additional evidence, beyond the reference itself, which could not be raised in an IPR, is introduced at the district court.

Cal. Inst. Of Tech. v. Broadcom Ltd., et al., CV 16-3714 (C.D. Cal. Dec. 28, 2018) (Dkt. No. 830)

Share This Insight

Previous Entries

IP Newsflash

March 24, 2025

The Federal Circuit affirmed a Patent Trial and Appeal Board (PTAB) final written decision holding that the prior art exception of AIA Section 102(b)(2)(B) does not apply to a prior sale by an inventor when the sale is conducted in private. According to the Federal Circuit, a sale must disclose the relevant aspects of the invention to the public to qualify for the prior art exception of Section 102(b)(2)(B).

...

Read More

IP Newsflash

March 21, 2025

Under the Lanham Act, a plaintiff who prevails on a trademark infringement claim may be entitled to recover the “defendant’s profits” as damages. The Supreme Court in Dewberry Group, Inc. v. Dewberry Engineers Inc. unanimously construed “defendant’s profits” in 35 USC § 1117(a) to mean that only the named defendant’s profits can be awarded, not the profits of other related corporate entities. The Court, however, left open the possibility that other language in § 1117(a) may allow for damages linked to the profits of related entities, if properly raised and supported.

...

Read More

IP Newsflash

March 13, 2025

In a series of rulings on a motion in limine, the District of Delaware recently distinguished between what qualifies as being incorporated by reference and what does not for the purposes of an anticipation defense. In short, a parenthetical citation was held to be insufficient, while three passages discussing a cited reference met the test.

...

Read More

IP Newsflash

March 4, 2025

On February 28, 2025, the USPTO announced that it was rescinding former Director Vidal’s 2022 memorandum on discretionary denials by the Patent Trial and Appeal Board. The 2022 memorandum effectively narrowed the application of discretionary denials in cases with parallel district court litigation by specifying instances where discretionary denial could not be issued. With the withdrawal of the memorandum, individual PTAB panels will regain flexibility in weighing discretionary denials. While the long-term effect of that increased flexibility is not yet known, the immediate effect is likely to be a shift towards the discretionary analysis applied by PTAB panels before the issuance of the memorandum.

...

Read More

IP Newsflash

March 3, 2025

A District of Delaware judge recently granted a defendant’s motion to include a patent prosecution bar in its proposed protective order after determining that litigation counsel’s ability to practice before the Patent Office—without ever having represented the plaintiffs at the Patent Office in the past—weighed heavily in favor of the bar.

...

Read More

IP Newsflash

February 12, 2025

The Federal Circuit recently reversed a district court decision that found a patent that did not describe after-arising technology failed to satisfy the written description requirement. In so doing, the Federal Circuit explained that written description and enablement are evaluated based on the subject matter that is claimed, not the products that practice those claims. As a result, the patentee was not required to describe unclaimed, later-discovered features of the accused products despite the broad language in the claims that undisputedly covered the products.

...

Read More

IP Newsflash

January 24, 2025

The District of Delaware recently rejected a patentee’s argument that non-production of an opinion letter from counsel, combined with knowledge of the patent, warranted a finding that defendant induced infringement.

...

Read More

IP Newsflash

January 17, 2025

The District of Delaware recently denied a motion to dismiss a patent infringement complaint involving gene editing technology that sought relief under the Safe Harbor Provision of the Hatch-Waxman Act. Specifically, the court found the patentee’s complaint sufficiently alleged at least some uses of the claimed technology that, when taken as true, were not solely uses of a “patented invention” that were “reasonably related” to an FDA submission.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.